Skip to main content
Premium Trial:

Request an Annual Quote

Ono Pharma Licenses Genedata's Software for Proteomics and Metabolomics Research

Premium

Genedata said last week that Ono Pharmaceutical has licensed its Genedata Expressionist for Mass Spectrometry solution and that the Japanese firm would use the tool in its proteomics and metabolomics research efforts.

Ono develops drugs for cancer and cardiovascular diseases. Its research requires "accurate mass profiling analysis as well as powerful [multiple reaction monitoring] capabilities for effective quantitative analysis," a spokesperson for Ono's Tsukuba Research Institute said in a statement.

Genedata's platform, the representative said, is able to integrate data from a variety of instruments and is able to identify clinically relevant biomarkers.

Genedata is not disclosing the financial details of the licensing agreement.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.